Active TB case finding in a high burden setting; comparison of community and facility-based strategies in Lusaka, Zambia.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 09 03 2020
accepted: 03 08 2020
entrez: 10 9 2020
pubmed: 11 9 2020
medline: 22 10 2020
Statut: epublish

Résumé

We conducted an implementation science study to increase TB case detection through a combination of interventions at health facility and community levels. We determined the impact of the study in terms of additional cases detected and notification rate and compared the yield of bacteriologically confirmed TB of facility based and community based case finding. Over a period of 18 months, similar case finding activities were conducted at George health facility in Lusaka Zambia and its catchment community, an informal peri-urban settlement. Activities included awareness and demand creation activities, TB screening with digital chest x-ray or symptom screening, sputum evaluation using geneXpert MTB/RIF, TB diagnosis and linkage to treatment. A total of 18,194 individuals were screened of which 9,846 (54.1%) were screened at the facility and 8,348 (45.9%) were screened in the community. The total number of TB cases diagnosed during the intervention period were 1,026, compared to 759 in the pre-intervention period; an additional 267 TB cases were diagnosed. Of the 563 bacteriologically confirmed TB cases diagnosed under the study, 515/563 (91.5%) and 48/563 (8.5%) were identified at the facility and in the community respectively (P<0.0001). The TB notification rate increased from 246 per 100,000 population pre-intervention to 395 per 100,000 population in the last year of the intervention. Facility active case finding was more effective in detecting TB cases than community active case finding. Strengthening health systems to appropriately identify and evaluate patients for TB needs to be optimised in high burden settings. At a minimum, provider initiated TB symptom screening with completion of the TB screening and diagnostic cascade should be provided at the health facility in high burden settings. Community screening needs to be systematic and targeted at high risk groups and communities with access barriers.

Identifiants

pubmed: 32911494
doi: 10.1371/journal.pone.0237931
pii: PONE-D-20-06815
pmc: PMC7482928
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0237931

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist

Références

PLoS One. 2016 Jul 21;11(7):e0159579
pubmed: 27442529
Int J Tuberc Lung Dis. 2018 Mar 1;22(3):264-272
pubmed: 29471903
BMC Pulm Med. 2018 May 2;18(1):64
pubmed: 29716569
PLoS One. 2014 Mar 27;9(3):e92754
pubmed: 24675985
Bull World Health Organ. 2018 Aug 1;96(8):522-530
pubmed: 30104792
Infect Dis Poverty. 2017 Jun 2;6(1):77
pubmed: 28571575
Int J Tuberc Lung Dis. 2013 May;17(5):608-14
pubmed: 23575325
BMC Health Serv Res. 2018 Dec 12;18(1):954
pubmed: 30541533
Int J Tuberc Lung Dis. 2005 Nov;9(11):1183-203
pubmed: 16333924
PLoS Med. 2019 Apr 30;16(4):e1002796
pubmed: 31039165
Public Health Action. 2016 Mar 21;6(1):15-8
pubmed: 27051605
Int J Tuberc Lung Dis. 2015 Aug;19(8):912-7
pubmed: 26162356
Lancet Infect Dis. 2012 Aug;12(8):608-16
pubmed: 22704778
Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1115
pubmed: 30236176
N Engl J Med. 2019 Oct 3;381(14):1347-1357
pubmed: 31577876
Int J Tuberc Lung Dis. 2011 Feb;15(2):205-10, i
pubmed: 21219682
PLoS One. 2016 Jan 15;11(1):e0146392
pubmed: 26771588
BMC Infect Dis. 2017 Jun 24;17(1):449
pubmed: 28646854

Auteurs

Mary Kagujje (M)

Tuberculosis Department, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Lophina Chilukutu (L)

Tuberculosis Department, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Paul Somwe (P)

Strategic Information Department, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Jacob Mutale (J)

Strategic Information Department, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Kanema Chiyenu (K)

Strategic Information Department, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Mwansa Lumpa (M)

Strategic Information Department, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Winfrida Mwanza (W)

Tuberculosis Department, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Monde Muyoyeta (M)

Tuberculosis Department, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH